Author Correction: PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation

Author Correction: PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation

Saved in:

Bibliographic Details
Main Authors:	Min Xie, Yan Yu, Rui Kang, Shan Zhu, Liangchun Yang, Ling Zeng, Xiaofang Sun, Minghua Yang, Timothy R. Billiar, Haichao Wang, Lizhi Cao, Jianxin Jiang, Daolin Tang
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-025-60997-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
by: Min Xie, et al.
Published: (2016-10-01)

Correction: Plumbagin protects mice from lethal Sepsis by modulating immunometabolism upstream of PKM2
by: Zhaoxia Zhang, et al.
Published: (2025-07-01)

Artemisia Extract Suppresses NLRP3 and AIM2 Inflammasome Activation by Inhibition of ASC Phosphorylation
by: Su-Bin Kwak, et al.
Published: (2018-01-01)

Cross-talk between NLRP3 and AIM2 inflammasomes in macrophage activation by LPS and titanium ions
by: Ana Belén Carrillo-Gálvez, et al.
Published: (2025-06-01)

NLRP3 and AIM2 inflammasomes exacerbate the pathogenic Th17 cell response to eggs of the helminth Schistosoma mansoni.
by: Madhusoodhanan Suresh Kumar Meena Kumari, et al.
Published: (2025-03-01)

HLA-F regulates the proliferation of trophoblast via PKM2-dependent glycolysis in the pathogenesis of preeclampsia
by: Ruiling Xu, et al.
Published: (2025-04-01)

TIPE drives a cancer stem-like phenotype by promoting glycolysis via PKM2/HIF-1α axis in melanoma
by: Maojin Tian, et al.
Published: (2024-12-01)

The RNA M5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated glycolysis
by: Qin Qi, et al.
Published: (2025-02-01)

Correction to: HNRNPC modulates PKM alternative splicing via m6A methylation, upregulating PKM2 expression to promote aerobic glycolysis in papillary thyroid carcinoma and drive malignant progression
by: Shikuo Rong, et al.
Published: (2025-02-01)

miR-142-3p Modulates Cell Invasion and Migration via PKM2-Mediated Aerobic Glycolysis in Colorectal Cancer
by: JunYu Ren, et al.
Published: (2021-01-01)

SULT2B1: a novel therapeutic target in colorectal cancer via modulation of AKT/PKM2-mediated glycolysis and proliferation
by: Jianxing Ma, et al.
Published: (2024-12-01)

BRG1 inhibits glycolysis by promoting SHP1-mediated dephosphorylation of PKM2 in non-small cell lung cancer
by: Wenli Zhan, et al.
Published: (2025-08-01)

NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
by: Jasna Klen, et al.
Published: (2015-01-01)

The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome
by: Lin Liang, et al.
Published: (2025-08-01)

GLP-1R activation attenuates the progression of pulmonary fibrosis via disrupting NLRP3 inflammasome/PFKFB3-driven glycolysis interaction and histone lactylation
by: Chenyang Liu, et al.
Published: (2024-10-01)

RETRACTED ARTICLE: Dihydroartemisinin enhances the anti-tumour effect of photodynamic therapy by targeting PKM2-mediated glycolysis in oesophageal cancer cell
by: Mengru Jin, et al.
Published: (2024-12-01)

Statement of Retraction: Dihydroartemisinin enhances the anti-tumor effect of photodynamic therapy by targeting PKM2-mediated glycolysis in esophageal cancer cell
Published: (2024-12-01)

NLRP3 inflammasome and pyroptosis: implications in inflammation and multisystem disorders
by: Xiaodi Li, et al.
Published: (2025-08-01)

Chlorogenic acid inhibits NLRP3 inflammasome activation through Nrf2 activation in diabetic nephropathy
by: Liping Bao, et al.
Published: (2025-01-01)

Correlation Analysis of Pyroptosis-Related Genes CASP1, NLRP3, AIM2, and NLRP1 With Lung Adenocarcinoma
by: Lingling Zhu, et al.
Published: (2025-01-01)

Angiogenin Ameliorates Endometritis by Inhibiting NLRP3 Inflammasome Activation
by: Jiangxue Cai, et al.
Published: (2025-07-01)

Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway
by: Jie Yang, et al.
Published: (2022-01-01)

The role of IGF2BP2 in macrophage-mediated NLRP3 inflammasome activation in the pathogenesis of dry AMD
by: Yuqing Zhao, et al.
Published: (2025-04-01)

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
by: Xingyong Wan, et al.
Published: (2016-01-01)

Research progress on NLRP3 inflammasome regulation of periodontitis
by: LI Xuejing, et al.
Published: (2024-02-01)

Diverse functions of NLRP3 inflammasome in PANoptosis and diseases
by: Yuanyuan Jiang, et al.
Published: (2025-08-01)

INFLAMMASOME NLRP1 DISTINCTIVE FEATURES IN ATOPIC CONDITIONS
by: Денис Сергеевич Загрешенко, et al.
Published: (2023-08-01)

NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)

Irisin Attenuates Neuroinflammation Targeting the NLRP3 Inflammasome
by: Francesca Martina Filannino, et al.
Published: (2024-11-01)

Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)

MicroRNAs as regulators of NLRP3 inflammasome activation in herpes simplex virus type 2 infection
by: Debashree Dass, et al.
Published: (2025-05-01)

Author Correction: Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2
by: Xiaowei Guo, et al.
Published: (2025-07-01)

Participation of NLRP3 inflammasome in the pathogenesis of idiopathic membranous nephropathy
by: Nan Lei, et al.
Published: (2021-01-01)

Bridging inflammation and venous thrombosis: the NLRP3 inflammasome connection
by: Jian Wu, et al.
Published: (2025-05-01)

Pinosylvin Inhibits Inflammatory and Osteoclastogenesis via NLRP3 Inflammasome
by: Wei Zhang, et al.
Published: (2025-08-01)

Molecular Mechanism of NLRP3 Inflammasome in Inflammatory Diseases and Tumors
by: Le‐Lan Gong, et al.
Published: (2025-07-01)

Expression of the Aim2 Inflammasome in Skeletal is Modulated by Surgical Bypass And is a Target to Reduce Ischemic Myopathy in Pad
by: Bowen Xie, et al.
Published: (2024-01-01)

Epimedin C alleviated osteoarthritis development by regulating chondrocyte Nrf2-mediated NLRP3 inflammasome axis
by: Changchang Liu, et al.
Published: (2024-12-01)

Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2
by: Leon L. Hsieh, et al.
Published: (2024-10-01)

PKM2-mediated metabolic reprogramming of microglia in neuroinflammation
by: Qi Zhang, et al.
Published: (2025-04-01)